JP Morgan Chase’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8
Closed -$95 7511
2024
Q4
$95 Buy
+8
New +$92 ﹤0.01% 7013
2023
Q4
Sell
-1
Closed -$11 7683
2023
Q3
$11 Buy
+1
New +$16 ﹤0.01% 7279
2021
Q3
Sell
-6
Closed -$1K 6638
2021
Q2
$1K Buy
+6
New +$1.42K ﹤0.01% 6252
2020
Q4
Hold
0
5765
2020
Q3
Hold
0
5610
2020
Q2
Hold
0
5521
2020
Q1
Sell
-19
Closed -$6K 5488
2019
Q4
$6K Buy
+19
New +$5.77K ﹤0.01% 5450
2019
Q3
Sell
-15
Closed -$5K 5839
2019
Q2
$5K Buy
+15
New +$6.11K ﹤0.01% 5627

Other funds holding IMNN

JP Morgan Chase's IMNN Position: Q1 2025 in Review

JP Morgan Chase sold out of Imunon (IMNN) in Q1 2025, closing a stake of 8 shares — an estimated $95 sold.

JP Morgan Chase first reported a position in IMNN in Q2 2019 and held it in 5 quarters. The position peaked at $6K in Q4 2019. 16 funds tracked by Wall St. Rank hold IMNN as of Q1 2025.

  • JP Morgan Chase reported no remaining Imunon position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 8 Imunon shares in Q1 2025, an estimated $95.
  • JP Morgan Chase first reported a position in Imunon in Q2 2019 and held it in 5 quarters.
  • JP Morgan Chase's Imunon position peaked at $6K in Q4 2019.
  • 16 funds tracked by Wall St. Rank held Imunon as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.